4893 items matching your search terms.

Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours

Shakespeare, TP; Gebski, VJ; Veness, MJ; Simes, J
LANCET, 2001     DOI:10.1016/s0140-6736(00)04522-0

Individualising treatment choice when interpreting clinical trial results. Clinical Trials Symposium

Simes, J.

Evaluating regional differences in international trials

Simes, J.

Effects of cholesterol treatments on stroke

Simes, J.

International differences in patient profile, treatment and outcomes

Simes, J.

International differences in the HERO-2 trial

Simes, J.

Clinical trials on-line

Simes, J.

Continuation of the FIELD study after the Heart Protection Study results

Simes, J.

Ethical issues in placebo controlled trials

Simes, J.

Positron emission tomography. Part 2(i)

Simes, J Howard, K

Importance of prolonged follow-up in showing the benefit of pravastatin in subgroups of patients with coronary heart disease: the LIPID trial

Simes, J.; Hunt, D.; Mulray, S.; Kirby, A.; Newman, P.; Tonkin, A.M.; for the LIPID study investigators,

Importance of prolonged follow-up in showing the benefit of pravastatin in subgroups of patients with coronary heart disease: the LIPID trial

Simes, J.; Hunt, D.; Mulray, S.; Kirby, A.; Newman, P.; Hague, W.; Tonkin, A. M.

Cholesterol-lowering therapy is more cost-effective for older than younger patients: results from the LIPID study

Simes, J; Tonkin, A; Kirby, A; Mulray, S; White, H; Glasziou, P; Sallaberger, M; Denton, M; Hunt, D

Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?

Simes, RJ; Coates, AS

A randomised, double-blind, comparator controlled study of the efficacy of sodium pentosan polysulfate injections and carprofen capsules in arthritic dogs

Smith, JG Hannon, RL Brunnberg, L Gebski, V Cullis-Hill, D